{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T04:02:19Z","timestamp":1745640139778,"version":"3.40.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s11845-025-03915-6","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T08:07:13Z","timestamp":1740557233000},"page":"507-513","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intestinal fatty-acid binding protein as a diagnosis marker in younger with celiac diseases"],"prefix":"10.1007","volume":"194","author":[{"given":"Ali A.","family":"Taha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaimaa Ibrahim","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ammar M. K.","family":"AL-Azzawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7655-6230","authenticated-orcid":false,"given":"Ekhlas Abdallah","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"3915_CR1","doi-asserted-by":"crossref","unstructured":"Storch J, Thumser AE (2000) The fatty acid transport function of fatty acid-binding proteins. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids 1486(1):28\u201344","DOI":"10.1016\/S1388-1981(00)00046-9"},{"key":"3915_CR2","doi-asserted-by":"publisher","unstructured":"Halfdanarson TR, Litzow MR, Murray JA (2007) Hematologic manifestations of celiac disease. https:\/\/doi.org\/10.1182\/blood-2006-07-031104","DOI":"10.1182\/blood-2006-07-031104"},{"key":"3915_CR3","doi-asserted-by":"publisher","unstructured":"Mart\u00edn-Masot R et al (2019) Multifactorial etiology of anemia in celiac disease and effect of gluten-free diet: a comprehensive review. https:\/\/doi.org\/10.3390\/nu11112557","DOI":"10.3390\/nu11112557"},{"key":"3915_CR4","doi-asserted-by":"publisher","unstructured":"Hoffbrand AV (1974) Anaemia in adult coeliac disease. https:\/\/doi.org\/10.1016\/s0300-5089(21)00352-7","DOI":"10.1016\/s0300-5089(21)00352-7"},{"key":"3915_CR5","doi-asserted-by":"publisher","unstructured":"Bottaro G, Cataldo F, Rotolo N et al (1999) The clinical pattern of subclinical\/silent celiac disease: an analysis on 1026 consecutive cases figure 1. Am J Gastroenterol 94(3). https:\/\/doi.org\/10.1111\/j.1572-0241.1999.00938.x","DOI":"10.1111\/j.1572-0241.1999.00938.x"},{"key":"3915_CR6","doi-asserted-by":"publisher","unstructured":"Gandini A et al (2022) Intestinal fatty acid binding protein (I-FABP) and CXC3L1 evaluation as biomarkers for patients at high-risk for coeliac disease in Johannesburg, South Africa. Cytokine 157. https:\/\/doi.org\/10.1016\/j.cyto.2022.155945","DOI":"10.1016\/j.cyto.2022.155945"},{"key":"3915_CR7","doi-asserted-by":"crossref","unstructured":"Logan M, MacKinder M, Clark CM et al (2022) Intestinal fatty acid binding protein is a disease biomarker in paediatric coeliac disease and Crohn\u2019s disease.\u00a0BMC Gastroenterol 22(1):260","DOI":"10.1186\/s12876-022-02334-6"},{"issue":"3","key":"3915_CR8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/apm.12800","volume":"126","author":"IB Oldenburger","year":"2018","unstructured":"Oldenburger IB, Wolters VM, Kardol-Hoefnagel T and others (2018) Serum intestinal fatty acid\u2013binding protein in the noninvasive diagnosis of celiac disease. APMIS 126(3):186\u2013190. https:\/\/doi.org\/10.1111\/apm.12800","journal-title":"APMIS"},{"key":"3915_CR9","doi-asserted-by":"publisher","unstructured":"Adriaanse MPM et al (2017) Progress towards non-invasive diagnosis and follow-up of celiac disease in children; a prospective multicentre study to the usefulness of plasma I-FABP. Sci Rep 7(1). https:\/\/doi.org\/10.1038\/s41598-017-07242-4","DOI":"10.1038\/s41598-017-07242-4"},{"key":"3915_CR10","doi-asserted-by":"publisher","unstructured":"Ho SS, Wall C, Gearry RB et al (2020) A pilot study evaluating novel urinary biomarkers for Crohn\u2019s disease Inflamm Intest Dis 5(4). https:\/\/doi.org\/10.1159\/000510682","DOI":"10.1159\/000510682"},{"key":"3915_CR11","doi-asserted-by":"publisher","unstructured":"Adriaanse MPM et al (2013) Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies. Aliment Pharmacol Ther 37(4). https:\/\/doi.org\/10.1111\/apt.12194","DOI":"10.1111\/apt.12194"},{"issue":"12","key":"3915_CR12","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.3109\/00365521.2011.627447","volume":"46","author":"AC Vreugdenhil","year":"2011","unstructured":"Vreugdenhil AC and others (2011) Additional value of serum I-FABP levels for evaluating celiac disease activity in children. Scand J Gastroenterol 46(12):1435\u20131441. https:\/\/doi.org\/10.3109\/00365521.2011.627447","journal-title":"Scand J Gastroenterol"},{"key":"3915_CR13","doi-asserted-by":"publisher","unstructured":"Singh P et al (2015) Titers of anti-tissue transglutaminase antibody correlate well with severity of villous abnormalities in celiac disease. J Clin Gastroenterol 49(3). https:\/\/doi.org\/10.1097\/MCG.0000000000000105","DOI":"10.1097\/MCG.0000000000000105"},{"key":"3915_CR14","doi-asserted-by":"publisher","unstructured":"Montoro-Huguet MA, Santolaria-Piedrafita S, Ca\u00f1amares-Orbis P, Garc\u00eda-Erce JA (2021) Iron deficiency in celiac disease: prevalence, health impact, and clinical management. https:\/\/doi.org\/10.3390\/nu13103437","DOI":"10.3390\/nu13103437"},{"issue":"2","key":"3915_CR15","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s11845-023-03502-7","volume":"193","author":"RF Lefta","year":"2024","unstructured":"Lefta RF, Hassan EA (2024) Serum soluble \u03b1-Klotho levels in patients with diabetic nephropathy. Irish J Med Sci (1971-) 193(2):725\u201331","journal-title":"Irish J Med Sci (1971-)"},{"key":"3915_CR16","doi-asserted-by":"publisher","first-page":"4614","DOI":"10.24996\/ijs.2021.62.12.2","volume":"30","author":"EA Hassan","year":"2021","unstructured":"Hassan EA, Hameed RY, Mezil SA (2021) Impacts of androgen abuse and overtraining on endocrine profile in bodybuilders. Iraqi J Sci 30:4614\u20134620","journal-title":"Iraqi J Sci"},{"issue":"31","key":"3915_CR17","doi-asserted-by":"publisher","first-page":"9233","DOI":"10.3748\/wjg.v21.i31.9233","volume":"21","author":"HJ Freeman","year":"2015","unstructured":"Freeman HJ (2015) Iron deficiency anemia in celiac disease. World J Gastroenterol 21(31):9233\u20139238. https:\/\/doi.org\/10.3748\/wjg.v21.i31.9233","journal-title":"World J Gastroenterol"},{"issue":"8","key":"3915_CR18","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.3390\/nu12082176","volume":"12","author":"G Stefanelli","year":"2020","unstructured":"Stefanelli G, Viscido A, Longo S and others (2020) Persistent iron deficiency anemia in patients with celiac disease despite a gluten-free diet. Nutrients 12(8):2176. https:\/\/doi.org\/10.3390\/nu12082176","journal-title":"Nutrients"},{"key":"3915_CR19","doi-asserted-by":"publisher","unstructured":"Not T et al (2011) Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet. Gut 60(11). https:\/\/doi.org\/10.1136\/gut.2010.232900","DOI":"10.1136\/gut.2010.232900"},{"key":"3915_CR20","doi-asserted-by":"publisher","unstructured":"Derikx JPM et al (2009) A pilot study on the noninvasive evaluation of intestinal damage in celiac disease using I-FABP and L-FABP. J Clin Gastroenterol 43(8). https:\/\/doi.org\/10.1097\/MCG.0b013e31819194b0","DOI":"10.1097\/MCG.0b013e31819194b0"},{"key":"3915_CR21","doi-asserted-by":"publisher","unstructured":"Duerksen DR, Wilhelm-Boyles C, Veitch R et al (2010) A comparison of antibody testing, permeability testing, and zonulin levels with small-bowel biopsy in celiac disease patients on a gluten-free diet. Dig Dis Sci 55(4). https:\/\/doi.org\/10.1007\/s10620-009-0813-5","DOI":"10.1007\/s10620-009-0813-5"},{"key":"3915_CR22","doi-asserted-by":"publisher","unstructured":"Vahedi K et al (2003) Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease. Am J Gastroenterol 98(5). https:\/\/doi.org\/10.1111\/j.1572-0241.2003.07284.x","DOI":"10.1111\/j.1572-0241.2003.07284.x"},{"key":"3915_CR23","doi-asserted-by":"publisher","unstructured":"Sbravati F et al (2022) Antitissue transglutaminase antibodies\u2019 normalization after starting a gluten-free diet in a large population of celiac children-a real-life experience. Dig Liver Dis 54(3). https:\/\/doi.org\/10.1016\/j.dld.2021.06.026","DOI":"10.1016\/j.dld.2021.06.026"},{"key":"3915_CR24","doi-asserted-by":"crossref","unstructured":"Gidrewicz D, Trevenen CL, Lyon M, Butzner JD (2017) Normalization time of celiac serology in children on a gluten-free diet.\u00a0J Pediatr Gastroenterol Nutr\u00a064(3):362\u2013367","DOI":"10.1097\/MPG.0000000000001270"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-025-03915-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-025-03915-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-025-03915-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T06:14:38Z","timestamp":1745561678000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-025-03915-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["3915"],"URL":"https:\/\/doi.org\/10.1007\/s11845-025-03915-6","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"type":"print","value":"0021-1265"},{"type":"electronic","value":"1863-4362"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Baquba Teaching Hospital Committee of Ethics and the Iraqi Ministry of Health\u2019s National Centre for Training and Human Development all permitted this study, which was carried out in accordance with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"1. All participation by individuals capable of giving informed consent as subjects in medical research voluntary, and to consult family members or community leaders, no individual capable of giving informed consent enrolled in a this research study unless he or she freely agrees.2. This medical research involved human subjects capable of giving informed consent, each subject was adequately informed of the aims, methods, sources of funding, any possible conflicts of interest, and institutional affiliations of this researcher.3. When I sought informed consent for participation in my research study, the subject was in a no relationship with the physician and no consent under duress.4. All subjects who are incapable of giving informed consent, not included in a research study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors contributed to this work.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financing sources"}}]}}